Nu Skin Enterprises (NUS)
(Real Time Quote from BATS)
$8.36 USD
+0.01 (0.12%)
Updated Sep 5, 2024 03:53 PM ET
After-Market: $8.37 +0.01 (0.12%) 4:16 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.36 USD
+0.01 (0.12%)
Updated Sep 5, 2024 03:53 PM ET
After-Market: $8.37 +0.01 (0.12%) 4:16 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
Bet on These 5 Top-Ranked Liquid Stocks for Fat Returns
by Radhika Pujara
Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.
Is Nu Skin Enterprises (NUS) a Good Value Investor Stock?
by Zacks Equity Research
Let's see if Nu Skin Enterprises (NUS) stock is a good choice for value-oriented investors right now from multiple angles.
NUS vs. EL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Nu Skin is Poised on Customer Base Growth & Product Pipeline
by Zacks Equity Research
Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
Inter Parfums Down on 2020 View, Travel Retail Woes to Stay
by Zacks Equity Research
Inter Parfums (IPAR) expects net sales of roughly $442 million for 2020, indicating a decline from 2019 levels. Travel retail is likely to remain under pressure.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Here's Why Nu Skin Stock is Up More Than 20% in Three Months
by Zacks Equity Research
Nu Skin (NUS) is seeing robust growth in its customer base courtesy of its effective strategies. Also, management recently raised its 2020 outlook.
Nu Skin (NUS) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: IBP, MED, NUS and LOGI
by Zacks Equity Research
Zacks.com featured highlights include: IBP, MED, NUS and LOGI
4 Best-Performing Liquid Stocks for Alluring Returns
by Radhika Pujara
Here are four excellent liquid stocks, including Logitech (LOGI), that can contribute to making an outstanding portfolio for investors.
Coty (COTY) Down on Wider-Than-Expected Q4 Loss & Drab Sales
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2020 results reflect adverse impacts of coronavirus-led retail and salon closures. The company expects to return to profits in the first quarter of fiscal 2021.
6 Stocks Near 52-Week Highs That Can Carry The Momentum Further
by Anirudha Bhagat
Investors will target stocks that have been on a bullish run lately. Stocks seeing price strength have higher chances of carrying the momentum forward.
NUS vs. HELE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Inter Parfums (IPAR) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Inter Parfums (IPAR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Altria Gains From Oral Products Amid Lower Cigarette Sales
by Zacks Equity Research
Despite dismal cigarette sales, pricing power and growth in oral tobacco are offering Altria (MO) some respite.
Estee Lauder's (EL) Q4 Loss Wider Than Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures. The company launches a two-year plan called Post-COVID Business Acceleration Program.
Nu Skin, AZZ, Regal Beloit and Rexnord highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nu Skin, AZZ, Regal Beloit and Rexnord highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Nu Skin (NUS)
by David Bartosiak
A big jump in earnings estimates means this stock deserves a new look.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Philip Morris Extends Deal With KT&G, RRPs Expansion on Track
by Zacks Equity Research
Philip Morris (PM) will start commercialization of KT&G's smoke-free alternatives outside South Korea, beginning with Russia.
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin